Japan launches commercial use of stem cell heart therapy
A Japanese hospital performed the first transplant of cardiac cell sheets derived from stem cells using a commercially approved treatment.
Written by EGazette’s AI. The facts are drawn from cited sources; the analysis is the AI’s own.
Japan has launched the commercial use of a new stem cell-based heart treatment, after a Japanese hospital performed what has been described as the world's first surgery to transplant sheets of cardiac muscle cells derived from stem cells.
According to one of the surgeons involved in the procedure, this treatment has received conditional government approval allowing it to be offered for commercial use — a world first in this medical field.
A promising technology
The technique involves transplanting thin sheets made of cardiac muscle cells derived from stem cells, with the aim of helping repair or regenerate damaged heart tissue in patients suffering from heart disease.
Full details regarding the number of patients targeted by this treatment or the associated costs have not yet been disclosed, as the medical community awaits further data on the initial outcomes of the procedure that was performed.
This step comes in the context of ongoing Japanese efforts to develop advanced stem cell-based therapies, with Japan considered one of the world's leading countries in regenerative medicine research for many years.
Specialists believe that the success of this type of therapy could open the door to similar applications for treating other conditions that require the repair or regeneration of damaged tissue, though the matter still requires further long-term studies and follow-up to evaluate its efficacy and safety on a wider scale.
Japanese authorities have not yet set a timeline for expanding the use of this treatment to include other hospitals within the country or abroad.
Sources
- اليابان تبدأ استخدام علاج للقلب بالخلايا الجذعية تجاريا — Sky News Arabia — Technology
EGazette summarizes reporting from multiple sources; follow the links for the originals.
Comments
Loading comments…
Related articles
Measles exposures spread to trains and sports venues as outbreaks grow
With active outbreaks in Pennsylvania, Ohio and New York, health officials are urging travellers to check their vaccination status before using shared transport.
Woman denied NHS breast reduction says condition causes daily pain and harassment
Charlotte Howard says she experiences unwanted comments in public and ongoing physical pain after being turned down for surgery.
Medicine prices soar in Iran as sanctions squeeze pharmaceutical supply
Patients and families are struggling to find some treatments as US sanctions pressure Iran's drug industry.
IVF 'Add-On' Treatments Offer Hope to Parents, But Scientific Evidence Remains Thin
Many fertility clinics offer optional IVF 'add-on' treatments to prospective parents, but researchers say there is little evidence that many of these interventions actually improve outcomes.
Patients switching from Wegovy injections to Novo's pill version kept losing weight, real-world study finds
Early real-world data suggest patients may not need weekly injections indefinitely to maintain weight loss on Wegovy.
Sedation Drugs Widely Used on Dementia Patients Despite Federal Push to Limit Them
A Michigan family's dispute over medicating their mother illustrates the difficult decisions families and guardians face over sedating medications in long-term care.